Technical Analysis for CRY - CryoLife, Inc.

Grade Last Price % Change Price Change
grade C 18.35 0.55% 0.10
CRY closed up 0.55 percent on Monday, May 22, 2017, on 50 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Down
See historical CRY trend table...

Date Alert Name Type % Chg
May 22 Narrow Range Bar Range Contraction 0.00%
May 19 Stochastic Reached Oversold Other 0.55%
May 18 NR7 Range Contraction 0.55%
May 18 Narrow Range Bar Range Contraction 0.55%
May 18 1,2,3 Pullback Bullish Bullish Swing Setup 0.55%
May 18 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.55%
May 16 Hammer Candlestick Bullish -3.42%
May 15 NR7 Range Contraction -2.91%
May 15 NR7-2 Range Contraction -2.91%
May 12 NR7 Range Contraction -2.65%

Older signals for CRY ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
CryoLife, Inc. preserves and distributes human tissues for transplantation in the United States and internationally. The company also develops, manufactures, and commercializes medical devices for cardiac and vascular applications. It distributes CryoValve SG pulmonary heart valves and CryoPatch SG pulmonary cardiac patch tissues that are processed using CryoLife's proprietary SynerGraft technology; and vascular tissues comprising CryoVein and CryoArtery to treat various vascular reconstructions, such as peripheral bypass, hemodialysis access, and aortic infections. The company also distributes surgical sealants and hemostats, including BioGlue Surgical Adhesive, an adjunct to sutures and staples for use in adult patients in open surgical repair of vessels, as well as in repair of cardiac, vascular, pulmonary, and additional soft tissues. In addition, its surgical sealants and hemostats comprise BioFoam Surgical Matrix for use as an adjunct in the sealing of abdominal parenchymal tissues, when cessation of bleeding by ligature or conventional methods is ineffective or impractical; PerClot, an absorbable powdered hemostat agent used in surgery; and revascularization technologies, which include transmyocardial revascularization system for treating patients with stable angina that is not responsive to conventional therapy. CryoLife, through its subsidiary Cardiogenesis Corporation, specializes in the treatment of coronary artery disease for severe angina using a laser console system and single use, fiber-optic handpieces to perform a surgical procedure known as Transmyocardial Revascularization. The company, through its subsidiary, Hemosphere, Inc., markets HeRO Graft, a solution for end-stage renal disease in certain hemodialysis patients. CryoLife distributes its products through field service representatives, cardiac specialists, direct field representatives, and independent distributors. The company was founded in 1984 and is headquartered in Kennesaw, Georgia.
Is CRY a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 20.15
52 Week Low 11.35
Average Volume 195,635
200-Day Moving Average 17.5176
50-Day Moving Average 16.969
20-Day Moving Average 18.3675
10-Day Moving Average 18.655
Average True Range 0.5016
ADX 42.02
+DI 27.45
-DI: 14.51
Chandelier Exit (Long, 3 ATRs) 17.8452
Chandelier Exit (Short, 3 ATRs) 16.8548
Upper Bollinger Band 19.7514
Lower Bollinger Band 16.9836
Percent B (%b) 0.49
Bandwidth 0.15069
MACD Line 0.4969
MACD Signal Line 0.6067
MACD Histogram -0.1098